Asthma

Sponsor:AstraZeneca Information provided by (Responsible Party):AstraZeneca This is a variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma inadequately controlled …

COPD

Sponsor:Sanofi Collaborator:Regeneron Pharmaceuticals Information provided by (Responsible Party):Sanofi Primary Objective: To evaluate the efficacy of dupilumab administered every 2 weeks in patients with moderate-or severe Chronic Obstructive Pulmonary Disease (COPD) …